Correction to: Screening for ferroptosis genes related to endometrial carcinoma and predicting of targeted drugs based on bioinformatics

Diagnostic and prognostic ROC curves based on the validated obtained hub genes. A–C Diagnostic ROC curves for CDKN2A, NRAS, and TFRC. D–F ROC analyses of CDKN2A, NRAS, and TFRC expression to predict the 1-, 3-, and 5-year OS periods in EC patients